June 2011 Briefing - Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for June 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Pain Is a Public Health Issue and Economic Burden in U.S.
THURSDAY, June 30 (HealthDay News) -- An integrated approach that responds to all the factors influencing pain can successfully treat, manage, and prevent chronic pain, according to a report published in June by the Institute of Medicine (IOM), on behalf of the National Institutes of Health (NIH).
Bottles of Tylenol Recalled
THURSDAY, June 30 (HealthDay News) -- The manufacturer of Tylenol is recalling one lot of U.S.-distributed Tylenol Extra Strength Caplets 225 count bottles, according to an announcement by the U.S. Food and Drug Administration.
No Clinical Benefit to Spinal Manipulative Therapy
THURSDAY, June 30 (HealthDay News) -- Despite having a small but significant effect, spinal manipulative therapy (SMT) does not appear to offer clinically relevant short-term pain relief and improved function for patients with chronic low-back pain compared to other interventions, according to a review published in the June 1 issue of Spine.
Silodosin Found to Reduce Chronic Prostatitis Symptoms
WEDNESDAY, June 29 (HealthDay News) -- Silodosin may provide symptomatic relief and improve quality of life for patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), according to a study published in the July issue of The Journal Of Urology.
In Lumbar Stenosis, ABI and TBI Needed for PAD Diagnosis
WEDNESDAY, June 29 (HealthDay News) -- In patients with lumbar spinal canal stenosis (LSCS) with or without normal arterial pulses, screening for peripheral artery disease (PAD) should include measuring the ankle brachial pressure index (ABI) and toe brachial pressure index (TBI), according to a study published in the July 1 issue of Spine.
Brief Intervention Helps Employees Return to Work
TUESDAY, June 28 (HealthDay News) -- A brief intervention is as efficient as multidisciplinary intervention for increasing one-year return to work (RTW) for sick-listed employees with low back pain (LBP), according to a study published in the July 1 issue of Spine.
Anti-TNF Doesn't Increase Complication Risk in Early RA
TUESDAY, June 21 (HealthDay News) -- Patients with early rheumatoid arthritis (RA) who are treated with anti-tumor necrosis factor (anti-TNF) therapy do not have an increased risk of serious infections and malignancies compared to those treated with methotrexate (MTX), according to a meta-analysis published in the June issue of Arthritis & Rheumatism.
Antirheumatic Drugs Linked to Lower Diabetes Risk
TUESDAY, June 21 (HealthDay News) -- Treatment of rheumatoid arthritis (RA) or psoriasis with biologic disease-modifying antirheumatic drugs (DMARDs), such as tumor necrosis factor (TNF) inhibitors, methotrexate, and hydroxychloroquine, may reduce the risk of newly recorded diabetes mellitus (DM), according to a study published in the June 22/29 issue of the Journal of the American Medical Association.
Millions in U.S. Do Not Receive PAD Prevention Therapies
TUESDAY, June 21 (HealthDay News) -- Millions of U.S. adults with peripheral artery disease (PAD) may not be receiving secondary prevention therapies, despite the fact that treatment with multiple agents is significantly correlated with lower all-cause mortality, according to a study published online June 20 in Circulation.
Abuse-Resistant Oxycodone Approved
MONDAY, June 20 (HealthDay News) -- Oxecta, an abuse-resistant form of the top-selling painkiller oxycodone, has been approved by the U.S. Food and Drug Administration.
Physical Therapy Post Lumbar Discectomy May Be Ineffective
FRIDAY, June 17 (HealthDay News) -- The effectiveness of outpatient physical therapy after first single-level lumbar discectomy is unclear, due to a lack of conclusive evidence, according to a review published in the June 15 issue of Spine.
Multifactorial Causes Linked to Increasing Opioid Deaths
THURSDAY, June 16 (HealthDay News) -- Opioid-related deaths occur due to multifactorial causes, and solutions are required to address all the causes, according to a review published online June 13 in a supplement of Pain Medicine.
Unequal Care Access for Children With Public Insurance
THURSDAY, June 16 (HealthDay News) -- Access to outpatient care is restricted for children with public insurance compared to those with private insurance, according to a study published in the June 16 issue of the New England Journal of Medicine.
Similar Number for Outpatient, Inpatient Malpractice Claims
TUESDAY, June 14 (HealthDay News) -- The number of paid malpractice claims is similar in both inpatient and outpatient settings, according to a study published in the June 15 issue of the Journal of the American Medical Association.
First Ceramic-on-Metal Hip Replacement Approved
TUESDAY, June 14 (HealthDay News) -- The first ceramic-on-metal total hip replacement system has been approved by the U.S. Food and Drug Administration.
Splints May Reduce Hand Pain in Hand Osteoarthritis
FRIDAY, June 10 (HealthDay News) -- Use of splints may reduce hand pain in patients with hand osteoarthritis, according to a review published online May 31 in Arthritis Care & Research.
Fibromyalgia Syndrome May Be Linked to Abuse
THURSDAY, June 9 (HealthDay News) -- Significant correlations may exist between fibromyalgia syndrome (FMS) and self-reported sexual and physical abuse in childhood and/or adulthood, according to a meta-analysis published in the June issue of Arthritis Care & Research.
Disability Pension Not Affected by Family Background
MONDAY, June 6 (HealthDay News) -- The incidence of disability pension (DP) due to low back disorders (LBD) is affected by sociodemographic and health-related factors independent of familial background, according to a study published in the May issue of the Journal of Occupational and Environmental Medicine.
Placebo or No Treatment Effective for Headache
FRIDAY, June 3 (HealthDay News) -- Individuals with headaches have an average recovery rate of 35.7 percent when they are in the placebo or no-treatment group of a trial, according to a review published online May 20 in the Journal of Manipulative and Physiological Therapeutics.
Precision Tinted Lenses May Help Reduce Migraine
THURSDAY, June 2 (HealthDay News) -- Use of precision ophthalmic tints (POTs) may reduce perceptual distortions and visual discomfort in migraine, possibly via a neurological pathway, according to a study published online May 26 in Cephalalgia.